ABS Laboratories has established a strong reputation in the bioanalysis and accurate quantification of drugs of abuse.
It currently provides analytical support to specialist investigators throughout the UK in the management of addiction.
It has also has active involvement in the development of new delivery systems for existing opiates (e.g. diamorphine, morphine, methadone, their antagonists; naloxone and naltrexone) together with cannabis derived medicines.
A screening service is available for these compounds a selection of which are listed below:
For any queries on the scope of the services provided please contact the business development team through the Quick Quotation link.